Seoul, South Korea

Hye Jeong Shin


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Hye Jeong Shin and Her Pioneering Patent

Introduction: Hye Jeong Shin, an accomplished inventor based in Seoul, South Korea, has made significant strides in the field of biopharmaceuticals. With a focus on autoimmune disease treatments, she holds a key patent that represents her innovations in this essential area of healthcare.

Latest Patents: Hye Jeong Shin is credited with a vital patent titled "Human Interleukin-1 Receptor Antagonist—Hybrid Fc Fusion Protein." This innovative fusion protein features an interleukin-1 receptor antagonist fused to a hybrid Fc fragment derived from human immunoglobulin. The unique composition includes IgD and IgG4, enhancing its potential therapeutic applications. The pharmaceutical composition derived from this patent promises superior efficacy and reduced side effects, paving the way for clinical development as therapeutic antibodies targeting autoimmune diseases such as rheumatoid arthritis, inflammatory bowel disease, psoriasis, and diabetes.

Career Highlights: Hye Jeong Shin's professional journey is highlighted by her impactful roles in leading biopharmaceutical companies. She has contributed her expertise to Handok Pharmaceuticals, Inc. and Genexine, Inc., where she has focused on the development of cutting-edge therapeutic solutions. Her dedication to research and innovation has solidified her reputation in the field.

Collaborations: Throughout her career, Hye Jeong Shin has collaborated with notable colleagues, including Young Gyu Cho and Woon Young Lee. These partnerships have fostered an environment of innovation and knowledge exchange, facilitating the development of promising new therapies.

Conclusion: Hye Jeong Shin stands out as a remarkable inventor whose work has the potential to reshape treatments for autoimmune diseases. Her pioneering patent reflects not only her individual achievements but also the collaborative spirit of scientific inquiry and innovation within the biopharmaceutical industry. As her work continues to advance, it offers hope for enhanced therapeutic strategies in the quest to improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…